What are Target-Specific DMARDs?
Written by: Emily Downward | Last reviewed: January 2019.
- Otezla product website, Celgene Corporation. Available at https://www.otezla.com/psoriatic-arthritis/. Accessed 3/20/18.
- Edwards CJ, Blano FJ, Crowley J, Birbana CA, Jaworski J, Aelion J, Stevens RM, Vessey A, Zhan X, Bird P. Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3). Ann Rheum Dis. 2016 Jun;75(6):1065-73. doi: 10.1136/annrheumdis-2015-207963. Epub 2016 Jan 20.
- Apremilast. Medline Plus, U.S. National Library of Medicine. Available at https://medlineplus.gov/druginfo/meds/a614022.html. Accessed 3/20/18.